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Fractionation of bioactive crude extracts of Chresta scapigera led
to the isolation of four triterpenes and five flavonoids, among them
β-amyrin acetate (1), 11α,12α-oxidetaraxeryl acetate (2) and
lupeol (3), as well as the flavonoids apigenin (6), kaempferol (7),
crysoeriol (8) and luteolin (9) were active against Leishmania
amazonensis amastigotes-like stages, while only the flavonoids (6),
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Plants have been traditionally used for the treatment
of diseases of different aethiology. Especially in the last
decade, phytotherapy has received considerable attention in
the search for alternatives to chemotherapy in parasitic
diseases control (Muelas-Serrano et al., 2000). Many of
these studies involve species of the Asteraceae family,
among which can be mentioned Lychnophora
granmongolense (Grael et al., 2000), Munnozia maronii
(Fournet et al., 1993), Vernonia brachycalyx (Oketch-
Rabah et al., 1998), Neurolaena lobata (Berger et al.,
2001), whose crude extracts and isolated compounds
presented antiprotozoal activity.
Leishmaniasis is a protozoan disease and occurs
widely in tropical areas in South America (Sauvain et al.,
1996). According to the WHO there are 2 million new ca-
ses of leishmaniasis per year worldwide (Barata et al.,
2000). This disease is caused by haemoflagellate protozoan
parasites that survive and multiply in magrophages in the
mammalian host and are transmitted by phlebotomine
sandflies (Salvador et al., 2002). The incidence of the
disease has increased in the last years, and the therapy
available mainly relies on antimonials, pentamidine and
amphotericin B, which are toxic, difficult to apply in the
field and not always effective (Mafezoli et al., 2000).
Another protozoan disease is South America
trypanosomiasis caused by Trypanosoma cruzi and
widespread though out the subcontinent with an estimated
18 million people infected (Barata et al., 2000). In Brazil
about 5-6 million people are infected, and of which 300,000
are located in São Paulo State. The population has been
infected mainly by contaminated blood transfusion for the
control of the insect vector (Ribeiro, Veloso, 1997). Gentian
violet is the only effective chemoprophylatic agent available
in blood banks. However, it is not completely accepted by
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clinicians or patients because of its undesirable effects such
as coloring the skin and possible mutagenic effects (Grael
et al., 2000; Coura, Castro, 2002). For the acute and
chronic diseases, the treatment is still a challenge today,
since the available drugs possess severe side effects and are
not completely efficient (Coura, Castro, 2002).
Thus, there is an urgent need for new drugs active
against Leishmania spp and Trypanosoma cruzi.
Chresta, belonging to Asteraceae family, is a small
genus that comprises 12 endemic species of the “Cerrado
brasileiro” (Robinson, 1999). There are no prior studies
about biological activity of this genus. The present studies,
crude extracts (roots, stem, leaves and inflorescences) and
some compounds isolated from Chresta scapigera were
evaluated for their ability to reduce viability of axenic
Leishmania amazonensis amastigotes and T. cruzi
trypomastigotes forms, in vitro.
MATERIAL AND METHODS
Plant material
Chresta scapigera was collected in Furnas (MG-
Brazil) in July, 1998, and identified by Dr. João Semir (Ins-
tituto de Biologia, Unicamp, Campinas, SP-Brazil). A
voucher of each specimen is deposited in the Herbarium of
FFCLRP/USP (SPFR6874).
Extraction and isolation process
Roots (188.0 g), stem (252.0 g), leaves (313.0 g)
and inflorescences (99.0 g) were separated, dried,
pulverized and stored in dark bags to protect them from
humidity and light. The powdered material was extracted
by maceration with n-hexane, dichloromethane and
ethanol, respectively, at room temperature. The n-hexanic
extract of roots (9.521 g) was chromatographed on a
column of silica gel 60 (0.063-0.200 mm, Merck), eluted
with hexane, ethyl acetate, methanol and mixtures of these
solvents of increasing polarity. This extract furnishes 18
fractions and the fractions 3 and 4 were purified by
preparative TLC yielding β-amyrin acetate (1) (16 mg)
and 11α,12α-oxidetaraxeryl acetate (2) (10 mg),
respectively. The n-hexanic extract of inflorescences
(2.594 g) was chromatographed in the same conditions
and furnishes 14 fractions. Preparative TLC was used to
purify the fractions 4 and 7, which yield lupeol (3)
(30 mg) and its acetate (4) (6 mg), respectively. The
ethanolic crude extract of inflorescence (2.6 g) was
partitioned between dichloromethane and methanol. The
hidroalcoholic phase (1.3 g) was submitted to filtration on
sephadex LH-20 and the fractions 6 and 7 were purified
by preparative HPLC in reverse phase (column ODS
Shimadzu 5 µm, 20 x 250 mm, eluent: methanol:water in
gradient, flow 9mL/min, UV detection: 280 nm) affording
tiliroside (5) (22 mg), apigenin (6) (12 mg) and
kaempferol (7) (10 mg), respectively. While the
dichloromethanic phase (391 mg) was chromatographed
on a silica gel column eluted with hexane, ethyl acetate,
methanol and mixtures of these solvents of increasing
polarity. The fraction 3 was purified by preparative TLC
affording crysoeriol (8) (3 mg). The ethanolic crude
extract of stem was chromatographed on PVP by vacuum
liquid chromatography eluted with CHCl3, methanol and
mixtures of these solvents of increasing polarity.
Filtration on sephadex LH-20 was used to purify the
fraction 1, which yield crysoeriol (8) (3 mg), apigenin (6)
(2 mg) and luteolin (9) (3 mg).
The structures of all compounds were determined by
spectroscopic methods (IR, 1H- and 13C-NMR). All
extracts and isolated compounds were evaluated against
axenic L.  amazonensis  amastigotes and T. cruzi
trypomastigotes forms, in vitro, according to a previous
report (Mafezoli et al., 2000; Bastos et al., 1999).
Trypanocidal activity
For the trypanocidal activity, blood of Swiss albino
mice infected with Trypanosoma cruzi (Y strain) was used,
which was collected by cardiac puncture at the peak of
parasitemia and was diluted to contain 106 trypomastigotes/
mL. Stock solutions (crude extracts) were prepared in 2.5%
of dimethyl sulfoxide (DMSO) and were added to blood
samples to provide a final concentration of 4000 µg/mL.
After incubation for 24 hours at 4 oC, the number of
parasites was determined according to Brener (1962). In the
tests, gentian violet (250 µg/mL) was used as positive
control and DMSO 2.5% as negative control. All
experiments were performed in triplicate.
Leishmanicidal activity
Axenic Leishmania (L.) amazonensis (strain
designation MPRO/BR/72/M 1841) amastigotes were
serially cultivated at 33 oC in modified UM-54 mediun
(Pral et al., 2003) and were used at the beginning of the
stationary phase. Washed parasites were resuspended in
RPMI-1640 medium supplemented with 4% fetal calf
serum, pH 5.0 and incubated at 33 oC for 24 hours with
crude extracts (1000 µg/mL) dissolved previously in
RPMI-1640. As controls, parasite suspensions were
incubated in RPMI alone or RPMI containing 0.1%
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FIGURE 1 - Structures of isolated compounds from C. scapigera.
DMSO. Amastigote viability was assessed colorimetrically
by reduction of a tetrazolium salt (MTT) as described by
Mosmann (1983). Amphotericin B (20 µg/mL) was used as
the positive control and DMSO/RPMI-1640 (1:99)
negative control. The experiments were carried out in
triplicate.
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RESULTS AND DISCUSSION
The results are showed in Tables I and II. All the
crude extracts evaluated markedly reduce the viability of L.
amazonensis amastigotes (at 1000 µg/mL), while only the
extracts hexanic of inflorescence, dichloromethanic of root
and ethanolic (root and stem) did not interfere appreciably
with lysis percentages of T. cruzi trypomastigotes forms (at
4000 µg/mL).
Data in Tables I and II show that effect of the
evaluated compounds varies depending on the different
concentrations used in the bioassay.
Compound (5) was not active against L. amazonensis
and T. cruzi at the concentrations evaluated, while the
compound (1) reduced the viability of L. amazonensis at the
lower concentration used (at 14 µg/mL), but not interfere
with lysis percentages of T. cruzi trypomastigote forms.
Flavonoids (6) and (9) were the most active ones when
assayed at 84 µg/mL against L. amazonensis, but a slight
activity was observed against T. cruzi.
Compound (6) presents a 5,7,4’-hydroxylation
pattern and showed active since 100 µg/mL with 54% of
lysis. Ribeiro et al. (1997) and Grael et al. (2000) have
demonstrated that hydroxylated flavonoids were more
active than methoxylated flavonoids when evaluated
against trypomastigote forms of T. cruzi. The authors
believed that the probable mechanism of action for this
activity might be explained from drugs that are able to
generate reactive oxygen species in which T. cruzi is
susceptible.
The other compounds interfered with viability of L.
amazonensis and T. cruzi at concentration evaluated.
The results presented can be considered promising
and these extracts may represent a source of active
substances against mainly amastigote forms of L.
amazonensis.
TABELA I -  In vitro leishmanial activity of crude extracts and compounds from C. sacpigera against axenic Leishmania
amazonensis amastigotes
Viability % of axenic Leishmania amazonensis amastigotes (SD)a
Evaluated material Concentration (µg/mL)
14 84 500 1000
hexanic extract of root — — — 0.96 ± 0.00
stem — — — 1.25 ± 0.00
leaves — — — 2.50 ± 0.00
inflorescence — — — 1.25 ± 0.00
dichloromethanic extract of root — — — 1.83 ± 0.00
stem — — — 3.08 ± 0.00
leaves — — — 0.77 ± 0.00
inflorescence — — — 3.27 ± 0.00
ethanolic extract of root — — — 2.31 ± 0.00
stem — — — 2.12 ± 0.00
leaves — — — 2.12 ± 0.00
inflorescence — — — 3.56 ± 0.00
Apigenin (6) 87.50 ± 0.01 16.23 ± 0.00 3.09 ± 0.00 —
Tiliroside (5) 100.00 ± 0.00 100.00 ± 0.00 67.8 ± 0.00 —
Kaempferol (7) 30.00 ± 0.56 21.00 ± 0.70 20.00 ± 0.17 —
Crysoeriol (8) 86.44 ± 0.02 73.10 ± 0.01 4.37 ± 0.00 —
Luteolin (9) 60.69 ± 0.02 16.32 ± 0.02 12.87 ± 0.00 —
β-amyrin acetate (1) 46.69 ± 0.04 36.17 ± 0.00 23.65 ± 0.00 —
11α,12α-oxidetaraxeryl acetate (2) 79.28 ± 0.04 50.16 ± 0.01 2.36 ± 0.00 —
Lupeol (3) 90.89 ± 0.08 71.02 ± 0.02 2.36 ± 0.00 —
Amphotericin B (20 µg/mL)b 3.37 ± 0.00
DMSO/RPMI-1640 (1:99)c 100.00 ± 0.02
a Parasite viability was determined by the MTT reduction assay; O.D. values are expressed as percent of those of untreated
(negative control) ± standard deviation; b positive control; c negative control; —: concentration did not evaluated. All
experiments were run in triplicate
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However, further studies (in vitro and in vivo) should
be accomplished in order to understand the mechanisms of
action, as well as to evaluate the toxicity, looking for a
clinical employment of those bioactive compounds.
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RESUMO
Efeito dos extratos e compostos isolados de Chresta
scapigera sobre a viabilidade de Leishmania
amazonensis e Trypanosoma cruzi
O fracionamento dos extratos bioativos de Chresta
scapigera proporcionou o isolamento de triterpenos e
TABELA II - In vitro trypanocidal activity of crude extracts and isolated compounds from C. scapigera against the
trypomastigote forms of Trypanosoma cruzi
Lysis % of T. cruzi trypomastigote ± (SD)a
Evaluated material Concentration (µg/mL)
100 250 500 4000
hexanic extract of root — — — 62.77 ± 2.19
stem — — — 100.0 ± 0.00
leaves — — — 100.0 ± 0.00
inflorescence — — — 24.82 ± 4.55
dichloromethanic extract of root — — — 42.37± 3.59
stem — — — 61.86 ± 7.62
leaves — — — 92.80 ± 2.64
inflorescence — — — 77.96 ± 6.39
ethanolic extract of root — — — 36.43 ± 2.54
stem — — — 44.91 ± 1.46
leaves — — — 70.76 ± 2.20
inflorescence — — — 50.85 ± 10.78
Apigenin (6) 54.57 ± 1.56 55.50 ± 2.41 62.46 ± 1.28 —
Luteolin (9) 44.88 ± 5.84 52.57 ± 8.00 58.98 ± 2.22 —
Tiliroside (5) 12.08 ± 2.60 17.08 ± 7.53 45.00 ± 0.00 —
11α,12α-oxidetaraxeryl acetate (2) 1.67 ± 3.53 17.08 ± 0.88 23.33 ± 3.53 —
β-amyrin acetate (1) 6.57 ± 0.92 20.61 ± 2.74 20.61 ± 0.76 —
lupeol acetate (4) 41.81 ± 5.14 78.80 ± 3.85 79.40 ± 2.09 —
lupeol (3) 6.67 ± 3.53 23.33 ± 4.38 23.75 ± 8.19 —
Gentian violet (250 µg/mL) b 0.00 ± 0.00
DMSO (2.5%)c 100.00 ± 0.00
a Results are expressed as lysis % of T. cruzi trypomastigote forms ± standard deviation (SD); b positive control (IC50=
31 µg/mL); c mice infected blood containing the same DMSO concentration used in the stocks solution (negative control)
did not interfere with parasite viability; —: concentration did not evaluated. All experiments were run in triplicate.
flavonóides, dentre os quais acetato de β-amirina (1),
acetate de 11α,12-oxidotaraxeril (2) e lupeol (3), assim
como os flavonóides apigenina (6), caenferol (7), crisoeriol
(8) e luteolina (9) mostraram-se ativos contra formas
amastigotas de Leishmania amazonensis, enquanto, apenas
os flavonóides (6), (7) e (9) apresentaram toxicidade con-
tra as formas tripomastigotas de Trypanosoma cruzi.
UNITERMOS: Chresta scapigera/atividade tripanocida.
Flavonóides. Triterpenos . Chresta scapigera/atividade
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